Argen-X Total Liabilities

Latest as of December 2025: €1.36 Billion EUR ≈ $1.59 Billion USD

Argen-X total liabilities. Based on the latest financial reports, Argen-X (1AE) has total liabilities worth €1.36 Billion EUR (≈ $1.59 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 1AE asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Argen-X (2016–2025)

Total liabilities of Argen-X from 2016 to 2025. This chart illustrates how Argen-X's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Argen-X to see how much of total assets are deployed in long-term investments.

Argen-X Competitors by Total Liabilities

The table below lists competitors of Argen-X ranked by their total liabilities.

Company	Country	Total Liabilities
Yum! Brands Inc NYSE:YUM	USA	$15.49 Billion
Entergy Corporation NYSE:ETR	USA	$52.87 Billion
Dollarama Inc TO:DOL	Canada	CA$6.10 Billion
RWE Aktiengesellschaft F:RWEA	Germany	€60.15 Billion
Kroger Company NYSE:KR	USA	$44.01 Billion
Woodside Energy Group Ltd NYSE:WDS	USA	$26.66 Billion
Live Nation Entertainment Inc NYSE:LYV	USA	$26.36 Billion
Microchip Technology Inc NASDAQ:MCHP	USA	$7.93 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Argen-X's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Argen-X.

Liquidity & Leverage Metrics

Argen-X Total Liabilities Ratios Explained

Argen-X total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	5.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Argen-X's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Argen-X (2016–2025)

The table below shows the annual total liabilities of Argen-X from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€1.36 Billion ≈ $1.59 Billion	+93.06%
2024-12-31	€704.24 Million ≈ $823.33 Million	+58.27%
2023-12-31	€444.95 Million ≈ $520.19 Million	+38.80%
2022-12-31	€320.56 Million ≈ $374.77 Million	+1.43%
2021-12-31	€316.05 Million ≈ $369.50 Million	-35.93%
2020-12-31	€493.32 Million ≈ $576.74 Million	+28.94%
2019-12-31	€382.59 Million ≈ $447.29 Million	+854.98%
2018-12-31	€40.06 Million ≈ $46.84 Million	+54.22%
2017-12-31	€25.98 Million ≈ $30.37 Million	-38.73%
2016-12-31	€42.40 Million ≈ $49.57 Million	--

About Argen-X

F:1AE Germany Biotechnology

Market Cap

$58.67 Billion

€50.19 Billion EUR

Market Cap Rank

#639 Global

#136 in Germany

Share Price

€807.00

Change (1 day)

+1.25%

52-Week Range

€566.40 - €910.00

All Time High

€910.00